Conferences - Results from #7860

ASCO 2018: Optimizing Androgen Receptor Targeting Strategies Perspective June 6, 2018

ASCO 2018: Approaches in Management of Refractory Germ Cell Cancer June 6, 2018

ASCO 2018: Long-Term Patterns in Race-specific, Distant Metastasis-free Survival Following Radiation Treatment for Prostate Cancer June 6, 2018

ASCO 2018: Impact of Treatment Sequence on the Outcomes of Metastatic Castration Resistant Prostate Cancer Patients With Germline BRCA2 Mutations: A Subanalysis of the PROREPAIR-B Study June 6, 2018

ASCO 2018: Survivorship and Surveillance in Management of Germ Cell Cancer June 6, 2018

ASCO 2018: CABOPRE: Phase II Study of Cabozantinib Prior to Cytoreductive Nephrectomy in Locally Advanced and/or Metastatic Renal Cell Carcinoma June 6, 2018

ASCO 2018: State-of-the-Art Management of Germ Cell Cancer June 6, 2018

ASCO 2018: PROPHECY - A Prospective Trial of Circulating Tumor Cell AR-V7 Detection in mCRPC with Abiraterone or Enzalutamide June 6, 2018

ASCO 2018: NIVES study: A Phase II Trial of Nivolumab Plus Stereotactic Body Radiotherapy in II And III Line of Patients with Metastatic Renal Cell Carcinoma June 6, 2018

ASCO 2018: Leveraging Social Media to Advance Cancer Research: Challenges and Opportunities June 6, 2018

ASCO 2018: KEYNOTE-199: Pembrolizumab for docetaxel-refractory Metastatic Castration-Resistant Prostate Cancer (mCRPC) June 6, 2018

ASCO 2018: KEYNOTE-564: A Phase 3, Randomized, Double Blind, Trial of Pembrolizumab in the Adjuvant Treatment of Renal Cell Carcinoma June 6, 2018

ASCO 2018: Nivolumab for Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma: A Single-Institution Experience June 6, 2018

ASCO 2018: Effectiveness and Safety of Pazopanib and Everolimus in a Changing Treatment Landscape: Interim Results of the Non-Interventional Study PAZOREAL June 6, 2018

ASCO 2018: Optimization of PD-L1 Algorithm for Predicting OS in Patients with Urothelial Cancer Treated with Durvalumab June 6, 2018

ASCO 2018: Association of Metastasis-Free Survival and Overall Survival in Non-Metastatic Castration-Resistant Prostate Cancer June 6, 2018

ASCO 2018: Precision Active Surveillance: Can Genomic Data Inform Management? June 6, 2018

ASCO 2018: Judicious Use of Therapeutics and Imaging in Early-Stage Prostate Cancer June 6, 2018

ASCO 2018: A Randomized Study of Finite Abiraterone Acetate Plus Leuprolide Versus Leuprolide in Biochemically Recurrent Non-Metastatic Hormone Naïve Prostate Cancer June 6, 2018

ASCO 2018: Prospective, Multinational, Observational Study of Real-World Treatment Outcomes with Pazopanib in Patients with Advanced or Metastatic Renal Cell Carcinoma (Principal Study) June 5, 2018

Page 394 of 614